Sociological investigations of human enhancement drugs: The case of microdosing psychedelics
International Journal of Drug Policy January 28, 2021 DOI: 10.1016/j.drugpo.2020.103099 (opens in new tab)
The journal has published a correction to this paper. Read the correction (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Topics | LSD Psilocybin Microdosing |
| Keywords | Phenomenon Narrative Hallucinogen |
| Citations | 17 |
| Key points | Proposes that microdosing psychedelics represents an emerging facet of human enhancement through drugs and identifies directions for sociological study. |
Abstract
Microdosing psychedelics is the regular use of sub-perceptive threshold doses of substances such as lysergic acid diethylamide (LSD) and psilocybin ('magic') mushrooms. The phenomenon has attracted increasing public and scientific attention in numerous countries in recent years. This commentary looks at microdosing psychedelics as an emerging facet of human enhancement through drugs. After presenting a narrative based on a multidisciplinary body of literature on human enhancement drugs and microdosing, the commentary maps out directions for further sociological studies of the phenomenon as well as outlining the different fields such research can contribute to.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Argues that microdosing psychedelics represents an emerging facet of human enhancement through drugs and maps directions for sociological study.
Synthesized
Citations in the library
Cited by 11
- Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins Journal of Psychopharmacology January 12, 2024
- Recreation and Realization: Reported Motivations of Use Among Persons Who Consume Psychedelics in Non-Clinical Settings July 26, 2021
- Unlocking the self: Can microdosing psychedelics make one feel more authentic? Nordisk alkohol- & narkotikatidskrift : NAT April 1, 2024
- Psychedelic assemblages Critique of Anthropology September 1, 2025
- Towards a dynamic processual model of psychedelic microdosing. International Journal of Drug Policy February 1, 2025
and 6 more in the library
Cites 21
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials Journal of Psychopharmacology March 8, 2012
- 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry May 1, 2018
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act Neuropharmacology June 5, 2018
and 16 more in the library